Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6103
Source ID: NCT03174522
Associated Drug: Rex-001
Title: The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Peripheral Arterial Disease (PAD)|Diabetes Mellitus (DM)|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Cardiovascular Disease|Critical Limb Ischemia (CLI)
Interventions: DRUG: REX-001|DRUG: Placebo
Outcome Measures: Primary: Complete healing of all ischemic ulcers on the index leg., Change in Rutherford classification from CLI Category 5 to Category 4 or lower 12 months. after administration of REX-001 or placebo., The primary endpoint for this trial will be assessed at 12 months. |
Sponsor/Collaborators: Sponsor: Ixaka Ltd | Collaborators: Andalusian Network for Design and Translation of Advanced Therapies
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 49
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2017-04-25
Completion Date: 2023-02-13
Results First Posted:
Last Update Posted: 2023-03-16
Locations: Fakultní nemocnice Ostrava, Ostrava, Czechia|Pécsi Tudományegyetem, PTE-KK I. sz Belgyógyászati Klinika, Pécs, Hungary|Leids Universitair Medisch Centrum, Leiden, Netherlands|Maastricht Universitair Medisch Centrum, Maastricht, Netherlands|Hospital Garcia de Orta, EPE, Almada, Portugal|Centro Hospitalar Lisboa Norte, EPE, Lisboa, Portugal|Centro Hospitalar de São João, Porto, Portugal|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitario Puerta del Mar, Cadiz, Spain|First site: Hospital Universitario Reina Sofía, Córdoba, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Regional Universitario, Málaga, Spain|University Hospital of Wales, Cardiff, United Kingdom
URL: https://clinicaltrials.gov/show/NCT03174522